Alector, Inc. (ALEC)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.46-1.99%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ALEC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 13.8 | 21.0 | 100.6 | 97.1 | 133.6 | 207.1 | 21.1 | 21.2 |
| Total Revenues | — | 21.0 | 100.6 | 97.1 | 133.6 | — | 21.1 | 21.2 |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 99.1 | 123.1 | 185.9 | 192.1 | 210.4 | 189.4 | 156.9 | 100.5 |
| Operating Income | (126.5) | (156.0) | (145.0) | (151.7) | (137.8) | (37.4) | (195.2) | (114.4) |
| Earnings from Continuing Operations | ||||||||
| EBT, Incl. Unusual Items | (117.6) | (142.8) | (118.9) | (125.1) | (130.1) | — | — | — |
| Income Tax Expense | — | 0.2 | 0.1 | 5.2 | 3.3 | 0.0 | 0.0 | — |
| Net Income | ||||||||
| Net Income | (117.9) | (142.9) | (119.0) | (130.0) | (133.3) | (36.3) | (190.2) | (105.4) |
| Per Share | ||||||||
| Basic EPS | (1.06) | (1.39) | (1.23) | (1.56) | (1.62) | (0.45) | (2.45) | — |
| Diluted EPS | (1.06) | (1.39) | (1.23) | (1.56) | (1.62) | (0.45) | (2.45) | — |
| Revenue per Share | 0.12 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 111.2 | 103.0 | 96.6 | 83.7 | 82.5 | 80.4 | 77.8 | — |
| Diluted Weighted Avg Shares | 111.2 | 103.0 | 96.6 | 83.7 | 82.5 | 80.4 | 77.8 | — |
| Supplemental | ||||||||
| EBITDA | — | (150.3) | (139.6) | (146.0) | (132.1) | (31.0) | (189.3) | (110.6) |
| EBIT | (126.5) | (156.0) | (145.0) | (151.7) | (137.8) | (37.4) | (195.2) | (114.4) |
| Effective Tax Rate | — | — | — | -4.2% | -2.5% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.